Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1995-5-10
pubmed:abstractText
To identify proteins involved in the formation of replication complexes at the 3' end of poliovirus negative-strand RNA, a combined in vitro biochemical and in vivo genetic approach was used. Five subgenomic cDNA constructs were generated to transcribe different negative-strand RNA fragments. In UV cross-linking assays, distinct differences in binding of proteins in extracts from poliovirus-infected and uninfected cells to virus-specific, radiolabeled transcripts were observed. Two proteins present in extracts from poliovirus-infected cells with approximate molecular masses of 36 and 38 kDa were shown to cross-link to the 3' end of poliovirus negative-strand RNA. Appearance of the 36- and 38-kDa proteins in UV cross-linking assays can be detected 3 to 3.5 h after infection, and cross-linking reaches maximum levels by 5 h after infection. The binding site for the 36-kDa protein overlaps with the computer-predicted loop b region of stem-loop I, the so-called cloverleaf structure, and the RNA sequence of this region is required for efficient binding. Transfection of full-length, positive-sense RNA containing a five-nucleotide substitution (positions 20 to 25) in the loop b region of stem-loop I into tissue culture cells yielded only viral isolates with a reversion at position 24 (U-->C). This finding demonstrates that the wild-type cytidine residue at position 24 is essential for virus replication. RNA binding studies with transcripts corresponding to the 3' end of negative-strand RNA suggest that complex formation with the 36-kDa protein plays an essential role during the viral life cycle.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-103625, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1315956, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1321289, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1355457, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1602550, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1652694, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1661029, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1731089, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1846205, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-1850039, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-198796, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2165605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2169386, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2170027, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2535728, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2547075, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2548189, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2835660, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2836612, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2838971, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-2839775, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-3001703, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-3003384, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-3010307, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-3018300, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-4287584, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6163133, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6244109, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6252335, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6280378, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6288718, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-6324172, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-7929441, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8039507, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8207812, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8230443, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8230467, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8253083, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8380467, http://linkedlifedata.com/resource/pubmed/commentcorrection/7707521-8500177
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2954-61
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA.
pubmed:affiliation
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine 92717, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't